Antibiotics and the Human Gut Microbiota

Introduction

Antibiotics make up a class of molecules whose purpose is to inhibit the growth of or kill harmful bacteria. Antibiotics originate from a wide variety of microbes as a means of competing with and defending themselves from nearby bacteria and are used to treat bacterial infections in humans (1,2). A microbiome is a population that is defined by every microbe present on and within an organism; for humans, it contributes immensely to the physiological processes of the host organism (3). Although antibiotics are incredibly useful in fighting bacterial infections, they often alter the human gut microbiome in ways that prove detrimental to our health.

Common Uses for Antibiotics

While antibiotics are primarily utilized to treat bacterial infections in humans, there are many other applications that significantly contribute to human antibiotic overexposure. Antibiotics are often used to treat and prevent bacterial infections in pets, livestock, and aquaculture (2). Additionally, antibiotics are used frequently to promote growth in livestock; certain studies estimate that the US uses more antibiotics for this purpose than for treatment of human bacterial infections (2c). Antibiotics are also included in many household products such as soaps, shampoos, and even solid objects such as fabrics (2). Aside from direct exposure, antibiotics and antibiotic resistant bacteria can come into contact with the human microbiota through waterway contamination (2a) and the consumption of food that is grown or produced in the presence of antibiotics (2b).

Effect of Antibiotic Exposure on the Human Microbiota

Due to the prevalence of antibiotic use throughout the world, the human microbiome is often exposed to excessive amounts of these antibacterial agents (2). Although antibiotics very effectively assist in the removal of harmful bacteria, they also have a significant effect on the gut microbiome. The most immediate of these effects is seen in the stress placed on the gut microbiome’s inhabitants, increasing expression of genes related to stress response, antibiotic resistance, and phage induction (2a). Bacterial fitness is altered in the presence of this stress, a change that tends to decrease bacterial diversity, richness and evenness within the gut; this disturbance is known as dysbiosis (2). Although the microbiome is generally able to return to a composition that is similar to that of pretreatment conditions (one study found this to occur about four weeks after five days of ciprofloxacin, although some taxa failed to recover until 6 months after treatment (5a)), some alterations to the microbiome have been shown to persist over a number of months (2b,2c). It was also found that when exposed to targeted antibiotics, certain subpopulations existing outside of their range of effectiveness can still experience a reduction in population size (6).

Antibiotic treatment and the resulting dysbiosis has been associated with a number of detrimental consequences. Although it is well known that antibiotic treatment leads to the selection for antibiotic resistance in pathogenic bacteria, this same type of selection occurs within the native inhabitants of the microbiome. Relatively high levels of antibiotic resistance genes have been shown to persist within the human gut microbiome for up to four years after antibiotic withdrawal (4). This is especially concerning when considering that such genes have been found to experience lateral transfer between distantly related bacterial species (2d), allowing the gut microbiome to act as a kind of storehouse for antibiotic resistance genes that can theoretically be accessed by dangerous bacteria during future infections (2). A more immediate concern following antibiotic treatment is an increased vulnerability to infection. Both the reduction in diversity of the gut microbiome and its domination by antibiotic resistant strains of certain bacteria have been linked to dangerous post-treatment infections. For example, antibiotic treated mice have shown increased susceptibility to Clostridium difficile-induced Colitis (2f) and bloodstream infection by vancomycin-resistant Enterococcus (2e). Early life dysbiosis resulting from antibiotic exposure has also been associated with an impaired immune response- leading to the development or enhancement of allergies, childhood asthma (2g), and various inflammatory disorders such as late onset sepsis (2h) and irritable bowel syndrome (2i). Treatment with antibiotics has been associated with increased weight gain in humans (2j) and an increased risk of obesity in mice (2k).

Conclusion

Overall text length should be at least 1,000 words (before counting references), with at least 2 images. Include at least 5 references under Reference section.

References

Edited by Zachary Baker, student of Joan Slonczewski for BIOL 116 Information in Living Systems, 2020, Kenyon College.